Sanjay Nayak, Chief Strategy Officer at OCULAR THERAPEUTIX, INC (OCUL), sold 1,895 shares at $6.84 ($13K) on 2025-02-24, disclosed to the SEC on 2025-02-26.
Open-market sale of $13k OCUL by Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OCUL | SELL | 2026-02-25 | $15K | — | Filing → |
| OCUL | SELL | 2026-02-17 | $94K | — | Filing → |
| OCUL | SELL | 2025-11-26 | $23K | — | Filing → |